MedTrace Logo

Nicardipine Versus Labetalol During Intubation

NCT01041066 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2009-12-31

No results posted yet for this study

Summary

The aim of this study was to compare the efficacy of nicardipine and labetalol in attenuation of cardiovascular responses to endotracheal intubation.

Conditions

  • Patients Who Are Intubated for General Anesthesia
  • Endotracheal Intubation

Interventions

DRUG

labetalol

0.4 mg/kg labetalol intravenously 4 min before intubation

DRUG

nicardipine

20 ㎍/kg nicardipine intravenously 4 min before intubation

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2009-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01041066 on ClinicalTrials.gov